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1. Introduction
The advent of real-time quantitative PCR has transformed the
discipline of pathogenic diagnostics. In comparison to convention-
al PCR, real-time PCR assays offer a greater detection range and
reproducibility, with significantly less inter-assay variation [1–4].
With its popularity, there has been rapid growth of commercially-
available real-time PCR master mixes and detection platforms,
which greatly increase the options available to laboratories [5,6].
These advances in options and technology have generated a need
for a periodic comparative evaluation, and such an opportunity
recently arose as part of a Joint National Preparedness Exercise
conducted by laboratories of the United States Army Research
Institute for Infectious Diseases (USAMRIID) and the Centers for
Disease Control and Prevention (CDC).
The Bioterrorism Rapid Response and Advanced Technology
(BRRAT) Laboratory of the CDC is charged with improving our
capabilities to detect Biological Select Agents and Toxins (BSAT)
that could be used as weapons of mass terror and warfare [7]. The
BRRAT laboratory, in collaboration with selected CDC subject
matter experts, has developed a number of real-time PCR assays for
BSAT detection [8]. These assays are deployed to reference
laboratories of the Laboratory Response Network (LRN), a network
of more than 160 state, federal and local public health, Department
of Defense (DOD), and veterinary laboratories that are poised
nationwide to rapidly detect and identify potential bio-threats [8].
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A B S T R A C T
The Centers for Disease Control and Prevention and United States Army Research Institute for Infectious
Diseases have developed real-time PCR assays for the detection of bioterrorism threat agents. These
assays all rely on a limited number of approved real-time PCR master mixes. Because the availability of
these reagents is a critical element of bioterrorism preparedness, we undertook a joint national
preparedness exercise to address the potential surge needs resulting from a large-scale bio-emergency.
We identified 9 commercially-available potential alternatives to an existing approved master mix
(LightCycler FastStart DNA Master HybProbes): the TaqMan Fast Universal PCR master mix, OmniMix HS,
FAST qPCR master mix, EXPRESS qPCR SuperMix kit, QuantiFast Probe PCR kit, LightCycler FastStart DNA
MasterPLUS HybProbe, Brilliant II FAST qPCR master mix, ABsolute Fast QPCR Mix and the HotStart IT Taq
master mix. The performances of these kits were evaluated by the use of real-time PCR assays for four
bioterrorism threat agents: Bacillus anthracis, Brucella melitensis, Burkholderia mallei and Francisella
tularensis. The master mixes were compared for target-specific detection levels, as well as consistency of
results among three different real-time PCR platforms (LightCycler, SmartCycler and 7500 Fast Dx). Real-
time PCR analysis revealed that all ten kits performed well for agent detection on the 7500 Fast Dx
instrument; however, the QuantiFast Probe PCR kit yielded the most consistently positive results across
multiple real-time PCR platforms. We report that certain combinations of commonly used master mixes
and instruments are not as reliable as others at detecting low concentrations of target DNA. Furthermore,
our study provides laboratories the option to select from the commercial kits we evaluated to suit their
preparedness needs.
Published by Elsevier Ireland Ltd.
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The LRN performs detection and identification assays for several
category A and B BSAT, including but not limited to Bacillus
anthracis, Yersinia pestis, Francisella tularensis, Burkholderia spp. and
Brucella spp. USAMRIID has independently developed assays for
these BSAT for use by the Department of Defense.
This joint study came about because the availability and
efficacy of our detection reagents are critical elements of our
bioterrorism preparedness [7]. During a catastrophic bioterrorism
attack or a naturally occurring pandemic, such reagents might
become limiting. As a matter of interagency planning for such
potential large-scale events, CDC and USAMRIID collaborated to
identify alternative master mixes that could, in the face of an
emergency, supplement our existing supplies of critical real-time
PCR reagents to insure that there would be sufficient deliverable
reagents to address any additional needs.
The goal of this study was to compare the performance of 9
newer commercial real-time PCR master mixes to our current
approved master mix for their ability to amplify and detect various
sizes and kinds of PCR targets from four representative BSAT
organisms: B. anthracis, B. melitensis, B. mallei and F. tularensis. The
kits were evaluated, with their corresponding real-time PCR
assays, by direct comparisons of the average cross-threshold (CT)
values under the demanding condition of DNA concentrations
approaching the limit of detection (LOD) for each BSAT. In addition,
the master mixes were evaluated for their cross-platform
portability by the use of three real-time PCR platforms.
2. Materials and methods
2.1. Biosafety procedures
All live specimen manipulations for DNA preparations were performed at
USAMRIID or the Critical Reagents Program (CRP) within biosafety level 3 (BSL-3)
facilities, as required, using practices outlined in the ‘‘Biosafety in Microbiological
and Biomedical Laboratories 5th Edition’’ [9]. PCR assays were conducted in BSL-2
facilities.
2.2. Commercial master mix kits
A market analysis was performed to identify commercial vendors that could
supply new master mix kits based on predetermined commercial capacity and
composition criteria. The goal was to identify suitable alternatives to our standard
real-time PCR master mix, the LightCycler FastStart DNA Master HybProbe kit
(Roche Applied Science, Indianapolis, IN), for emergency use in a surge event.
Possible vendors were identified that possessed viable candidates. A set of
modifiable scoring criteria was created based on the projected needs of the LRN.
The criteria for determining suitable ‘‘surge supplements’’ was that the new
reagent(s) should be able to substitute for existing LRN and USAMRIID validated
reagents in all of their Standard Operating Protocols (SOP) for BSAT detection, with
a minimum of changes to their SOP (i.e., they should be able to fulfill a protocol
plug-in-and-play scenario), fulfilling the same role as the current master mix
without changes to cycling parameters that would necessitate a revalidation of
approved protocols or risk procedural differences leading to unintentional
ambiguity. A total of 9 such master mixes were identified for comparative
evaluation (Table 1).
The LightCycler FastStart DNA Master Hybridization Probes (10) kit (Roche),
henceforth referred to as Roche I, was provided with LightCycler – FastStart enzyme
(vial 1a) and LightCycler-FastStart Reaction Mix (vial 1b), which were first
combined as directed, then mixed with appropriate amounts of 25 mM MgCl2
(usually to 4 mM). The LightCycler FastStart DNA Master Hybridization ProbesPLUS
5 kit (Roche II) comes with the MgCl2 added to the buffer, which is complete after
adding the 5 polymerase. The other 8 master mixes come as a 2 concentration
with the DNA polymerase, pre-optimized MgCl2, and reaction buffer pre-combined
in a single tube.
2.3. Culture and DNA extraction of BSATs
The Unified Culture Collection (UCC) is a library of BSAT organisms and their
nucleic acid extracts that is maintained by the DSD of USAMRIID for the Critical
Reagents Program (CRP) of the Aberdeen Proving Ground-Edgewood Area, MD. DNA
of four representative category A and B BSAT (provided from the CRP by Gerald
Howe of DSD-USAMRIID) were used in this study: B. anthracis strain Ames (UCC,
DNA-BACI008), B. melitensis strain 16M (UCC, BRUC013D-CRP07), B. mallei strain
010 (UCC, BURK010D-CRP07) and F. tularensis strain LVS (UCC, DNA-FRAN004).
Genome sizes used to determine LODs for each BSAT were obtained from GenBank
(http://www.ncbi.nlm.nih.gov/sites/entrez) and as described [10–12].
The DNA was extracted directly from bacterial cultures and was then safety-
tested against the presence of viable organisms before use. These DNA were cesium
chloride gradient purified, quantified, and dispensed as 5 ng of DNA per vial, then
stored at 70 8C. We performed the appropriate calculations to determine the
genome copy (gc) equivalents per nanogram of DNA for each organism and
resuspended the DNA accordingly to 100,000 gc/ml in 10 mM Tris (pH 8.0). Ten-fold
serial dilutions of the DNA were then prepared to obtain four log-order differences
of concentration of target DNA for each organism (i.e., 20,000, 2000, 200 and 20 gc
per reaction). Further dilutions in Tris were made as needed.
2.4. Real-time PCR
The real-time PCR assays used in this study have been used by USAMRIID for
the in vitro qualitative presumptive detection of BSAT DNA in environmental
samples, clinical specimens and culture isolates and have been described in
previous reports [13–15]. We used the following four primer and probe sets:
BALB (chrom.), which detects a chromosomal gene of B. anthracis; omp2a,
targeting the outer membrane protein 2a gene of B. melitensis; bimAma,
targeting an actin polymerization gene of B. mallei; and tul4, for F. tularensis
(Table 2). Prior to rehydration, dry primers and probes were stored at 2–8 8C in
the dark. Each tube was rehydrated to appropriate concentrations with 10 mM
Tris (pH 8.0). The rehydrated aliquots of primers and light-sensitive probes were
stored in the dark at 2–8 8C for the duration of the study. The four signature sets
were tested against a 10-fold dilution series, as described above, of their
purified target DNAs.
Real-time PCR was conducted according to the agent-specific SOPs. The final
volume of each reaction mixture was 25 ml and was comprised of an average of
4 mM MgCl2 (range 3–8 mM), 200–1000 nM specific primers (as SOP specified), 25–
200 nM TaqMan probe, with 5 ml of purified BSAT template DNA to give the desired
gc number per reaction volume, and 5 ml of PCR-grade water or Tris to the no-
template-control reactions. Thermal cycling was performed using the following
program: one cycle at 95 8C for 8 min for Hot-Start Taq activation, followed by 45
cycles of 95 8C for 5 s and 60 8C for 30 s. A fluorescence reading was taken at the end
of each 60 8C step. These same cycle conditions were used for all instruments used
in this study.
Initial rounds of testing were conducted using the 7500 Fast Dx instrument
(Applied Biosystems, Foster City, CA) with the Roche I master mix, to obtain a
relative baseline LOD for each BSAT. The average CT values at each DNA
concentration were calculated from triplicate samples at each DNA concentration.
The LOD was determined to be the lowest concentration for which triplicate
samples resulted in a similar positive result, as measured by CT values  45. Further
performance testing of the 10 master mixes was done, conducted as described
above with the 7500 Fast Dx, but at a single DNA concentration that was three times
the experimentally established LOD (3 LOD). The kits were then ranked for
performance based on comparisons of mean CT values.
Table 1
Summary of the ten commercial master mix kits evaluated in this study.
Manufacturer Master mix kit Catalog number
Applied Biosystems (ABI) TaqMan Fast Universal PCR master mix 4352042
Cepheid OmniMix HS OMNL1-100N-050
Eurogentec FAST qPCR master mix plus Low ROX RT-QP2X-03 + WOULRF-2
Invitrogen EXPRESS qPCR SuperMix kit 11785-200
Qiagen QuantiFast Probe PCR + ROX kit 204352
Roche (I) LightCycler FastStart DNA Master HybProbe 12-239-272-001
Roche (II) LightCycler FastStart DNA MasterPLUS HybProbe 3515575001
Stratagene Brilliant II FAST QPCR master mix with Low ROX 600806
Thermo Fisher Scientific ABsolute Fast QPCR Mix Plus ROX AB-4325-A
USB HotStart-IT Taq master mix 71196
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2.5. Comparison of the master mixes on two additional real-time PCR platforms
Based on the above testing results, surge candidates were next evaluated for
performance on two additional platforms, the SmartCycler (Cepheid, Sunnyvale,
CA) and the LightCycler (Roche). Performance testing was again conducted in
triplicate for each signature group at 3 LOD. For each BSAT, the mean CT values for
triplicate wells were calculated for each master mix, and these values were
compared to each other and to those of the approved Roche I master mix.
2.6. Data analysis
The real-time PCR data was analyzed using the appropriate software supplied for
each platform. For example, the 7500 Fast System Dx SDS with v1.4 21 CFR Part 11
Module software (Applied Biosystems) using the ‘Delta Rn versus Cycle’ mode. For
the LightCycler, each capillary tube was read in Channel 1 (F1) at a gain setting of 16.
The data was analyzed with LightCycler data analysis software version 3.5.3
(Roche). Sample curves were analyzed by using the second derivative maximum
with the baseline adjustment set to arithmetic. For the SmartCycler, data were
analyzed using the SmartCycler software version 1.2d (Cepheid). The SmartCycler
settings consisted of a primary curve analysis with a manual threshold setting of 10,
background subtraction turned on, boxcar average set to five cycles, background
minimum cycle set to 5, and background maximum cycle set to 45. Real-time PCR
results with CT values greater than 45 were considered negative.
3. Results
3.1. Real-time PCR limit of detection for four BSAT
The LOD for the four BSAT was determined with the Roche I
master mix as a baseline for comparative evaluations of the 9
master mixes identified in this study. Fig. 1 shows the real-time
PCR LOD for B. anthracis, B. melitensis, B. mallei and F. tularensis on
the 7500 Fast Dx instrument. Generally, the LODs for the four
BSATs were comparable with the Roche I master mix. The LOD for
B. anthracis, B. melitensis, and B. mallei was 10 gc, while the LOD for
F. tularensis was 5 gc.
3.2. Comparison of the ten master mixes on the 7500 Fast Dx
instrument
Table 3 shows real-time PCR results for the 10 commercial
master mixes on the 7500 Fast Dx instrument, with CT values
corresponding to three times the experimentally determined LOD
for the four BSATs. Taken as a whole, most of the 9 master mix
candidates were roughly equivalent or superior to the currently
used Roche kit (Roche I) with each BSAT. However, there were four
kits that ranked in the top three for performance on the 7500 Fast
Dx with two or more agents: the ABI, Eurogentec, Invitrogen, and
Qiagen kits.
Individually, for the B. anthracis detection assay, there were 6
master mixes that performed as well as or better than the Roche I
master mix. The Invitrogen kit ranked first, with the lowest average
CT value, followed by the ABI and Eurogentec master mixes,
whereas the Stratagene kit ranked last with the highest average CT
value. A total of 8 master mixes performed as well or better than
the Roche I master mix for B. melitensis, with two pairs that
resulted in equivalent results (ABI with Thermo Fisher Scientific
and Cepheid with USB). The top three master mixes for B. mallei
detection were ABI, Eurogentec, and Thermo Fisher Scientific,
whereas the Cepheid master mix resulted in the worst perfor-
mance. As for F. tularensis, five master mixes performed as well or
better than the Roche I master mix, with the Qiagen master mix
ranking first and three master mixes tied for last place (Cepheid,
Roche II and Stratagene). There was no significant difference in
mean CT values between the Roche I master mix and the 9 other
master mixes for B. anthracis, B. mallei and F. tularensis; however,
the Qiagen master mix resulted in significantly better detection for
B. melitensis than the Roche I kit [as measured by 1 log-unit
difference in detection levels (CT value difference  3.3)].
Table 2
Primer and probe sequences for real-time PCR assays used to compare ten commercial master mixes for detection of bioterrorism threat agents.
Primer or probea Target Nucleotide sequence (50 ! 30) Amplicon size (bp)
BALB-F41 B. anthracis (chromosome) TGGCGGAAAAGCTAATATAGTAAAGTA 106
BALB-R-146 CCACATATCGAATCTCCTGTCTAAAA
BALB-P-88-MGB ACTTCTAAAAAGCAGATAGAAAT
OMP2a-F1755 B. melitensis (outer membrane protein 2a) CCAGGCGTACCGGTTATCTC 101
OMP2a-R1845 AGACCCTTTTGAGGTCTACTCCCTTA
OPM2A-p1799-MGB TGGTCGAAGGCGCTC
BMSEC3-F-49 B. mallei (polymerase gene) CAGTTGATTCTCCCACC 96
BMSEC3-R-144 TGTCTTGTTGAGCATGAGA
BMSEC3-P-104R-MGB CATACGGATGTATAGAACCAAT
Tul4-F-774 F. tularensis (tul4 gene) CAGCATACAATAATAACCCACAAGG 103
Tul4-R-876 TCAGCATACTTAGTAATTGGGAAGC
Tul4-P-809S TTACAATGGCAGGCTCCAGAAGGTT
a Information taken from Bode et al. [13] for the B. anthracis assay, Christensen et al. [14] for the B. melitensis and F. tularensis assays, and Ulrich et al. [15] for the B. mallei
assay.
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Fig. 1. Quantitative detection of B. anthracis (*), B. melitensis (&), B. mallei (~) and
F. tularensis (^), using the real-time PCR assays described by Bode et al. [13],
Christensen et al. [14] and Ulrich et al. [15] with the LightCycler FastStart DNA
Master HybProbe (Roche I). Serial dilutions of purified bacterial DNA from each
bioterrorism threat agent were prepared, and the assays were performed in
triplicate with samples at each concentration on the 7500 Fast Dx instrument. The
data was plotted as the mean of CT values for triplicate samples versus the genomic
DNA copy numbers. The limit of detection (LOD) was determined to be the lowest
concentration for which three out of three replicates produced a positive result.
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3.3. Evaluation of the ten master mixes on multiple real-time PCR
platforms
The 10 master mixes were further evaluated for BSAT detection
on two additional real-time PCR instruments. Fig. 2 shows the real-
time PCR results for B. anthracis, B. melitensis, B. mallei and F.
tularensis at 3 LOD with the 7500 Fast Dx, LightCycler and
SmartCycler platforms. By and large there was great variability in
BSAT detection among the three instruments, and several master
mix failures for detection on the LightCycler platform. For B.
anthracis, all 10 of the master mixes resulted in positive results on
the 7500 Fast Dx and the SmartCycler instruments; however, four
of the master mixes, the ABI, Eurogentec, Invitrogen, and
Stratagene, resulted in negative results on the LightCycler
(Fig. 2A). Similarly, all of the master mixes demonstrated cross-
platform portability between the 7500 Fast Dx and SmartCycler
platforms, but three failed to detect B. melitensis on the LightCycler
(ABI, Eurogentec, and Stratagene) (Fig. 2B). A total of 5 master
mixes failed for detection of B. mallei on the LightCycler
instrument, while all 10 resulted in positive results on the 7500
Fast Dx and SmartCycler (Fig. 2C). Likewise, all 10 master mixes
resulted in positive results for F. tularensis on the 7500 Fast Dx and
SmartCycler instruments, whereas three failed on the LightCycler
(ABI, Eurogentec and Stratagene) (Fig. 2D).
3.4. Comparison of costs and pipetting steps
Table 4 shows comparison of costs and number of pipetting
steps between the commercial master mix kits. The kits were
ranked from 1 to 10 in order of increasing cost per PCR reaction. Of
the 10 master mix kits, the USB kit was the least expensive,
followed by the Eurogentec kit, then the ABI kit. The Cepheid
Table 3
Comparison of ten commercial master mixes for detection of bioterrorism threat agents by real-time PCR.
Master mix Average CT (mean  SD)a
B. anthracis Ranking B. melitensis Ranking B. mallei Ranking F. tularensis Ranking
ABI 33.9  0.46 2 30.2  0.15 5 30.0  0.16 1 28.1  0.14 4
Cepheid 35.4  0.84 8 30.4  0.12 6 33.7  0.80 10 29.2  0.37 8
Eurogentec 34.0  0.50 3 29.2  0.34 3 30.2  0.08 2 27.7  0.15 3
Invitrogen 33.5  1.59 1 29.5  0.43 4 31.2  0.61 4 27.5  0.41 2
Qiagen 34.5  0.27 6 27.1  0.81 1 31.5  2.63 5 27.2  0.41 1
Roche I 35.3  0.53 7 31.9  0.56 7 32.9  0.40 8 28.4  0.31 6
Roche II 36.5  0.37 9 32.6  0.34 8 33.3  0.46 9 29.2  0.33 8
Stratagene 36.8  0.64 10 29.0  0.19 2 31.8  0.35 6 29.2  0.41 8
Thermo FS 34.5  1.13 5 30.2  0.33 5 30.6  0.70 3 28.2  0.28 5
USB 34.3  0.21 4 30.4  0.08 6 32.0  0.61 7 28.6  0.28 7
a The ten master mixes were evaluated by use of agent-specific real-time PCR assays (Bode et al. [13], Christensen et al. [14] and Ulrich et al. [15]) on the 7500 Fast Dx
instrument. Average CT values (mean  SD) are shown for triplicate samples of purified genomic DNA at three times the determined limit of detection (Fig. 1), with rankings from 1
to 10 in order of increasing CT values.
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Fig. 2. Multi-platform comparison of ten commercial master mixes for real-time PCR detection of B. anthracis (A), B. melitensis (B), B. mallei (C) and F. tularensis (D). Purified
bacterial DNA from each bioterrorism threat agent was prepared and the assays [13–15] were performed in triplicate using DNA at three times the experimentally determined
limit of detection. For each kit, the data is plotted as the average CT values (mean  SD indicated by error bars) for triplicate samples on the 7500 Fast Dx, LightCycler, and
SmartCycler instruments.
G.S. Buzard et al. / Forensic Science International 223 (2012) 292–297 295
master mix kit was by far the most expensive per assay of the kits
evaluated in this study.
The master mix kits were also compared for the number of
pipetting steps required to set up a PCR reaction. This comparison
only included steps that were unique to a master mix and excluded
all common steps (e.g., addition of template DNA). With the
exception of the two Roche master mix kits, all of the kits were
provided as one-step PCR reaction mixtures; the Roche I kit
required three pipetting steps, while the Roche II kit required two.
4. Discussion
The LRN currently has only two master mix kits validated to be
used for their BSAT testing; by far the primary one is the
LightCycler FastStart DNA Master HybProbes (Roche), but in one
unusual agent-specific case the Fast Universal PCR master mix
(Applied Biosystems) can be used as well. USAMRIID is faced with a
similar challenge, with its primary use of a Platinum Taq mixture. A
potential concern arose that there might not be enough deliverable
master mix reactions in stock, either in surge capacity storage by
the CDC or at the manufacturer. As part of our ongoing efforts to
improve surge preparedness, we sought to identify additional real-
time PCR master mixes that could be used in the case of a large-
scale emergency event. Therefore, in this joint agency effort
between CDC and USAMRIID, we compared 9 new kits to our
current kit as candidates for such an emergency use.
Previous studies have compared either the performance
characteristics of a small number of commercially-available
real-time PCR reagents or compared only a small number of
signature sets. In 1998, Al-Soud and Radstrom [16] evaluated 9
different PCR enzymes and their associated reaction buffers (the
precursors to today’s master mixes). Their study [16] used one
signature set and examined the ability of certain PCR enzymes to
amplify in the presence of common PCR-inhibiting components
found in complex biological samples. Subsequently, Wolffs et al.
[17] investigated four DNA polymerases (Taq, DyNazyme, Tth and
rTth) and two different buffer systems in real-time PCR and showed
that the choice of both the type DNA polymerase and the buffer
system affected amplification efficiency. In our study, we
compared 10 commercial reagents by the use of real-time PCR
assays for four different select agents in an effort to provide a
thorough evaluation of the most popular kits that are currently on
the market. Real-time PCR CT values were used for quantitative
comparisons of master mix reagent performance; however, it
should be noted that quantitative detection is not necessary for
routine diagnostics or during a bio-threat emergency when only
the presence or absence of the target agent is in question.
Successful detection and identification of BSAT organisms
depends crucially on both the quantity and quality of the DNA
samples being analyzed [5]. In this study, highly purified DNA
templates were used to determine the LOD for the four BSATs on
the 7500 Fast Dx instrument. Although it is unlikely that highly
purified DNA would be used as template during a bio-threat
emergency, we chose this approach because it offers several
advantages for master mix reagent evaluations, including the
ability to accurately convert DNA concentration to genomic copy
numbers, and it reduces the potential bias introduced by inhibitory
contaminants left by some DNA extraction processes. Our results
showed that, with these conditions, most of the new master mix
kits performed as well or better on the 7500 Fast Dx than the
current Roche master mix for all four BSATs. However, the
individual kit results were not always uniformly equivalent, in that
several kits ranked among the top three for one agent and its
signature, but not for others (Table 3). These results indicate that
even when the DNA is highly purified, as in the case of our
experiments, the choice of and concentration of reaction mix
components, such as primers, probes, analytical platforms, and
cycling conditions, can affect assay sensitivity. For the purposes of
this study, a significant difference in master mix reagent
performance was defined as CT value differences  3.3. Although
this criterion was acceptable for evaluating and ranking differences
in detection levels, is important to note that it is not acceptable for
all applications, such as studies involving gene expression where
smaller differences between cycle numbers could be relevant.
More relevant to our current study, Sohni et al. [5] recently
evaluated 5 commercial TaqMan PCR reagent kits in assays for B.
anthracis. Their study showed that three of the 5 kits performed
better for B. anthracis detection. However, a limitation of their
study was that it was done on a single type of real-time PCR
platform. Previous studies have reported significant variability in
PCR efficiency and results among different types of thermal cyclers
[18,19]. There are three different types of LRN-approved real-time-
PCR detection platforms, represented in this study by the
LightCycler (Roche), the SmartCycler (Cepheid) and the 7500 Fast
Dx (Applied Biosystems). We chose to do our evaluations on these
instruments after careful thought regarding the varying detection
throughput capacities in diagnostic laboratories; the SmartCycler
is a 16-reaction vessel per block instrument, the LightCycler has a
32-sample capacity, and the 7500 Fast Dx has a 96-well capacity.
Most PCR systems employ pre-determined settings and
proprietary master mixes that differ from one system to another.
These differences affect detection, as Lu et al. [20] showed,
comparing the 7500 (Applied Biosystems) and the LightCycler 480
(Roche) instruments, using their default settings, proprietary
reagents, ramp rates and magnesium concentrations. Two targets
readily detected by the 7500 system were not detected using the
LightCycler 480 system [20]. Our findings were consistent with
those observations, as three of the kits that performed best in our
initial studies on the 7500 Fast Dx, the ABI, Eurogentec and
Invitrogen kits, failed on the LightCycler (Table 3 and Fig. 2).
We hypothesize that these failures on the LightCycler are
attributed to the absence of bovine serum albumin in these master
mixes, which is required to prevent absorption of the Taq
polymerase to the glass capillaries used with the LightCycler
instrument. Additionally, Bentley et al. [21] demonstrated that
several critical parameters might need to be optimized when
converting between real-time PCR platforms, including optimiza-
tion of the MgCl2 concentration and changes in PCR cycling
parameters, such as dwell times and ramping speeds. This is not
always the case, however. Christensen et al. [14] compared the
Table 4
Comparison of costs and pipetting steps between the ten commercial master mix
kits.
Manufacturer Ranking for Cost/PCR reactiona No. of pipetting stepsc
ABI 2 1
Cepheid 10 1
Eurogentec 3 1
Invitrogen 6 1
Qiagen 9 1
Roche I 8b 2
Roche II 7b 3
Stratagene 4 1
Thermo FS 5 1
USB 1 1
a The cost per reaction was calculated by dividing the cost for each commercial
kit, based on the manufacturer’s list price in summer of 2011 (U.S. dollars), by the
number of PCR reactions (25 ml each) that could be performed with each kit. The kits
were ranked from 1 to 10 based on cost per PCR reaction, with 1 corresponding to
the least expensive and 10 for the most expensive.
b These two mixes were the same price per reaction.
c Pipetting steps include those unique to a master mix, such as mixing from
separate tubes of polymerase, magnesium chloride and reaction buffer, where
applicable.
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performance of assays for 7 biological threat agents on the
R.A.P.I.D. (Idaho Technology, Inc., Salt Lake City, UT) the Light-
Cycler, and the SmartCycler, and found that their assays gave
comparable results for performance, sensitivity and specificity on
all three platforms. Based on the results of this study [14], and to
meet our selection criteria of maintaining current BSAT assay
conditions, we evaluated the master mixes on three real-time PCR
instruments using identical thermal cycling conditions.
The primary real-time PCR master mix that is currently used for
the LRN’s BSAT assays comes in three tubes that must be mixed
together prior to setting up the rest of the PCR reactions. In 8 of the
newer commercial master mix systems, these three components
are pre-mixed into one tube (Table 4). In the 9 new candidate kits
we compared, the concentration of magnesium was already
optimized for the master mix and no additional adjustments
were needed or made. The concentrations of polymerase,
nucleotides, magnesium and buffers in these newer master mixes
are also pre-optimized for the faster PCR ramping conditions now
widely utilized. Pre-combining them in a single tube reduces
handling, and hence minimizes pipetting steps and contamination
risks. Second generation commercial reaction mixes such as those
evaluated in this study have now made it far easier for assay set-up,
with fewer steps, less time, fewer risks of contamination or error,
while improving the reproducibility and reliability of the assays.
One limitation of our study was that we did not evaluate the
master mixes utilizing the optimal conditions prescribed by each
respective kit manufacturer. As the goal of this study was to
identify suitable alternatives, its design defaulted to the conditions
currently used with the optimized BSAT assays. Future studies
should evaluate commercial kits utilizing the optimized assay
conditions, as well as the manufacturers’ recommended condi-
tions.
This joint-agency study was conducted to find equivalent or
superior alternatives to our current real-time PCR master mix
reagents to ensure that we will have sufficient product capacity in
the case of a surge event. At completion, our analysis has identified,
at a minimum, four additional sources of superior master mix that
can be used on the 7500 Fast Dx instrument in the case of a surge
event: the TaqMan Fast Universal PCR master mix from Applied
Biosystems, the FAST qPCR master mix from Eurogentec, the
EXPRESS qPCR SuperMix Universal kit from Invitrogen, and the
QuantiFast Probe PCR kit from Qiagen. Of these four kits, the
Qiagen kit demonstrated the best cross-platform portability from
the 7500 Fast Dx to two additional instruments, the LightCycler
and SmartCycler. While all of the kits evaluated in this study have
features which laboratories may wish to consider, we found these
four kits to be the best alternatives to our current master mix.
Disclaimer statement
‘‘The findings and conclusions in this report are those of the
authors and do not necessarily represent the official position of the
Centers for Disease Control and Prevention/the Agency for Toxic
Substances and Disease Registry, nor the U.S. Army. Names of
vendors or manufacturers are provided as examples of available
product sources; inclusion does not imply endorsement of the
vendors, manufacturers or products by the Centers for Disease
Control and Prevention, the U.S. Department of Health and Human
Services, the U.S. Army, or the Department of Defense.’’
B. anthracis, B. melitensis, B. mallei, and F. tularensis are select
agents and their possession, use, and transfer are regulated by the
U.S. Department of Health and Human Services, Centers for Disease
Control and Prevention, and/or the U.S. Department of Agriculture,
Animal and Plant Health Inspection Service. The select agent
regulations have mandatory reporting requirements for identifi-
cation of select agents in diagnostic specimens.
Acknowledgements
We would like to thank the following USAMRIID researchers for
supplying materials and helpful suggestions: Tim Minogue, Gerald
Howe, Kitty Baldwin and Deanna Christensen. We thank Harvey
Holmes and Judy Sheldon for their contributions to this study. We
also thank the following CDC researchers for their editorial
comments: JanettaHakovirta, David Sue, Kenyatta Stephens and
Roblena Walker.
References
[1] C.J. Gerard, K. Olsson, R. Ramanathan, C. Reading, E.G. Hanania, Improved quanti-
tation of minimal residual disease in multiple myeloma using real-time poly-
merase chain reaction and plasmid-DNA complementarity determining region III
standards, Cancer Res. 58 (1998) 3957–3964.
[2] M. Puig, K. Mihalik, M.Y. Yu, S.M. Feinstone, M.E. Major, Sensitivity and repro-
ducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR
assay, J. Virol. Methods 105 (2002) 253–263.
[3] S.J. Wall, D.R. Edwards, Quantitative reverse transcription-polymerase chain
reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time
RT-PCRs, Anal. Biochem. 300 (2002) 269–273.
[4] S.A. Bustin, Quantification of nucleic acids by PCR, in: S.A. Bustin (Ed.), A–Z of
Quantitative PCR, International University Line, La Jolla, CA, 2004, pp. 16–17.
[5] Y. Sohni, S. Kanjilal, V. Kapur, Performance evaluation of five commercial real-
time PCR reagent systems using TaqMan assays for B. anthracis detection, Clin.
Biochem. 41 (2008) 640–644.
[6] K.W. Stephens, R.J. Hutchins, L.A. Dauphin, Cross-platform evaluation of commer-
cial real-time reverse transcription PCR master mix kits using a quantitative 50-
nuclease assay for Ebola virus, Mol. Cell. Probes 24 (2010) 370–375.
[7] A.S. Khan, S. Morse, S. Lillibridge, Public-health preparedness for biological
terrorism in the USA, Lancet 356 (2000) 1179–1182.
[8] L.D. Rotz, J.M. Hughes, Advances in detecting and responding to threats from
bioterrorism and emerging infectious disease, Nat. Med. 10 (2004) S130–S136.
[9] U.S. Department of Health and Human Services, CDC, NIH, Biosafety in Microbio-
logical and Biomedical Laboratories, Washington, DC, 5th ed., 2007.
[10] V.G. DelVecchio, V. Kapatral, P. Elzer, G. Patra, C.V. Mujer, The genome of Brucella
melitensis, Vet. Microbiol. 90 (2002) 587–592.
[11] W.C. Nierman, D. DeShazer, H.S. Kim, H. Tettelin, K.E. Nelson, T. Feldblyum, R.L.
Ulrich, C.M. Ronning, L.M. Brinkac, S.C. Daugherty, T.D. Davidsen, R.T. Deboy, G.
Dimitrov, R.J. Dodson, A.S. Durkin, M.L. Gwinn, D.H. Haft, H. Khouri, J.F. Kolonay, R.
Madupu, Y. Mohammoud, W.C. Nelson, D. Radune, C.M. Romero, S. Sarria, J.
Selengut, C. Shamblin, S.A. Sullivan, O. White, Y. Yu, N. Zafar, L. Zhou, C.M. Fraser,
Structural flexibility in the Burkholderia mallei genome, Proc. Natl. Acad. Sci. U.S.A.
101 (2004) 14246–14251.
[12] P. Larsson, P.C. Oyston, P. Chain, M.C. Chu, M. Duffield, H.H. Fuxelius, E. Garcia, G.
Halltorp, D. Johansson, K.E. Isherwood, P.D. Karp, E. Larsson, Y. Liu, S. Michell, J.
Prior, R. Prior, S. Malfatti, A. Sjostedt, K. Svensson, N. Thompson, L. Vergez, J.K.
Wagg, B.W. Wren, L.E. Lindler, S.G. Andersson, M. Forsman, R.W. Titball, The
complete genome sequence of Francisella tularensis, the causative agent of tula-
remia, Nat. Genet. 37 (2005) 153–159.
[13] E. Bode, W. Hurtle, D. Norwood, Real-time PCR assay for a unique chromosomal
sequence of Bacillus anthracis, J. Clin. Microbiol. 42 (2004) 5825–5831.
[14] D.R. Christensen, L.J. Hartman, B.M. Loveless, M.S. Frye, M.A. Shipley, D.L. Bridge,
M.J. Richards, R.S. Kaplan, J. Garrison, C.D. Baldwin, D.A. Kulesh, D.A. Norwood,
Detection of biological threat agents by real-time PCR: comparison of assay
performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms,
Clin. Chem. 52 (2006) 141–145.
[15] M.P. Ulrich, D.A. Norwood, D.R. Christensen, R.L. Ulrich, Using real-time PCR to
specifically detect Burkholderia mallei, J. Med. Microbiol. 55 (2006) 551–559.
[16] W. Abu Al-Soud, P. Radstrom, Capacity of nine thermostable DNA polymerases to
mediate DNA amplification in the presence of PCR-inhibiting samples, Appl.
Environ. Microbiol. 64 (1998) 3748–3753.
[17] P. Wolffs, H. Grage, O. Hagberg, P. Radstrom, Impact of DNA polymerases and their
buffer systems on quantitative real-time PCR, J. Clin. Microbiol. 42 (2004)
408–411.
[18] D. Schoder, A. Schmalwieser, G. Schauberger, M. Kuhn, J. Hoorfar, M. Wagner,
Physical characteristics of six new thermocyclers, Clin. Chem. 49 (2003) 960–963.
[19] D. Schoder, A. Schmalwieser, G. Schauberger, J. Hoorfar, M. Kuhn, M. Wagner,
Novel approach for assessing performance of PCR cyclers used for diagnostic
testing, J. Clin. Microbiol. 43 (2005) 2724–2728.
[20] S. Lu, A.P. Smith, D. Moore, N.M. Lee, Different real-time PCR systems yield
different gene expression values, Mol. Cell. Probes 24 (2010) 315–320.
[21] H.A. Bentley, D.R. Belloni, G.J. Tsongalis, Parameters involved in the conversion of
real-time PCR assays from the ABI prism 7700 to the Cepheid SmartCycler II, Clin.
Biochem. 38 (2005) 183–186.
G.S. Buzard et al. / Forensic Science International 223 (2012) 292–297 297
